BHST
BHST
NASDAQ · Consumer products

Bioharvest Sciences Inc

$1.51
+0.05 (+3.42%)
As of Nov 6, 3:25 PM ET ·
Financial Highlights (FY 2026)
Revenue
34.82M
Net Income
-34,518,228
Gross Margin
44.4%
Profit Margin
-99.2%
Rev Growth
+217.5%
D/E Ratio
0.93
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 44.4% 48.9% 48.9% 48.9%
Operating Margin -78.6% 10.7% 11.8% 10.5%
Profit Margin -99.2% 11.5% 10.8% 10.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 34.82M 79.81M 72.35M 77.50M
Gross Profit 15.48M 39.05M 35.41M 37.92M
Operating Income -27,382,525 8.54M 8.53M 8.10M
Net Income -34,518,228 9.14M 7.84M 7.97M
Gross Margin 44.4% 48.9% 48.9% 48.9%
Operating Margin -78.6% 10.7% 11.8% 10.5%
Profit Margin -99.2% 11.5% 10.8% 10.3%
Rev Growth +217.5% +14.6% +12.0% -2.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 13.54M 71.15M 71.70M 68.34M
Total Equity 14.53M 76.04M 83.93M 92.20M
D/E Ratio 0.93 0.94 0.85 0.74
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -26,241,884 10.94M 9.97M 9.95M
Free Cash Flow — 7.79M 6.73M 8.70M